Personalizing therapies for gastric cancer: Molecular mechanisms and novel targeted therapies

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 38

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

432

HTML

4279

Figures (1-3)

219

Tables (1-3)

227

Sum=5157

Publishing Process of This Article

Item

Count

Browse

1023

Download

937

Sum=1960

Oct 14, 2013 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Oct 14, 2013; 19(38): 6383-6397
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6383

Full Size Figure Download Figure

Figure 1 Human epidermal growth factor receptor 2 and binding sites. I-IV: Epidermal growth factor receptor 1-4.

Citation: Luis M, Tavares A, Carvalho LS, Lara-Santos L, Araújo A, Mello RA. Personalizing therapies for gastric cancer: Molecular mechanisms and novel targeted therapies. World J Gastroenterol 2013; 19(38): 6383-6397
URL: https://www.wjgnet.com/1007-9327/full/v19/i38/6383.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i38.6383